Skip to main content

AusPAR: Adalimumab (rch)

Australian Public Assessment Report
Device/Product Name
Humira
Active ingredients
Adalimumab (rch)
AusPAR Date
Published
Sponsor
Submission Number
PM-2014-01048-1-3
Submission Type
Extension of indications
Decision
Approved

Help us improve the Therapeutic Goods Administration site